Letaxaban, also known as TAK-442, is a potent, selective, and orally active factor Xa inhibitor, which is a tetrahydropyrimidin-2(1H)-one derivative. TAK-442 inhibited endogenous FXa activity in platelet-poor human [half-maximal inhibitory concentration (IC(50)): 53 nM, TAK-442] and rat (IC(50): 32 nM, TAK-442) plasma.
More Information Supplier PageLetaxaban, also known as TAK-442, is a potent, selective, and orally active factor Xa inhibitor, which is a tetrahydropyrimidin-2(1H)-one derivative. TAK-442 inhibited endogenous FXa activity in platelet-poor human [half-maximal inhibitory concentration (IC(50)): 53 nM, TAK-442] and rat (IC(50): 32 nM, TAK-442) plasma.
More Information Supplier PageLetaxaban, also known as TAK-442, is a potent, selective, and orally active factor Xa inhibitor, which is a tetrahydropyrimidin-2(1H)-one derivative. TAK-442 inhibited endogenous FXa activity in platelet-poor human [half-maximal inhibitory concentration (IC(50)): 53 nM, TAK-442] and rat (IC(50): 32 nM, TAK-442) plasma.
More Information Supplier PageRazaxaban is a selective, potent, and orally bioavailable inhibitor of coagulation factor Xa.
More Information Supplier PageRazaxaban is a selective, potent, and orally bioavailable inhibitor of coagulation factor Xa.
More Information Supplier PageRazaxaban is a selective, potent, and orally bioavailable inhibitor of coagulation factor Xa.
More Information Supplier PageRazaxaban is a selective, potent, and orally bioavailable inhibitor of coagulation factor Xa.
More Information Supplier Page
